Group 1 - The core viewpoint of the article is that the strategic cooperation agreement between New World Resources Trading–FZCO and Zhiyun Kuangshi Limited marks a significant step for both companies in enhancing their digital technology capabilities and business development [1][2] - New World Resources will prioritize purchasing cloud computing and internet traffic services from Zhiyun Kuangshi, ensuring that the terms are equal to or better than those offered by other service providers [1] - Zhiyun Kuangshi will regard New World Resources as a core strategic customer, prioritizing its operational capacity and internet traffic needs when resources are available [1] Group 2 - The board believes that this strategic cooperation will promote the development of both companies by leveraging their respective strengths in digital technology [2] - The expected outcome of the cooperation is to secure a stable supply of operational capacity and internet traffic services under more favorable commercial terms, enhancing the consistency, quality, and competitiveness of the software-as-a-service (SaaS) solutions offered by the group [2] - This partnership is anticipated to lower overall costs, supporting the long-term development of the new SaaS solution business [2]

Core Viewpoint - The strategic cooperation agreement between New World Resources Trading – FZCO and Zhiyun Kuangshi Limited aims to enhance procurement and supply of cloud computing and internet traffic services, marking a significant step for both companies in leveraging their strengths in digital technology [1][2]. Group 1 - New World Resources will prioritize procurement of cloud computing and internet traffic services from Zhiyun Kuangshi, ensuring that the terms are equal to or better than those offered by other service providers [1]. - Zhiyun Kuangshi will regard New World Resources as a core strategic customer, prioritizing its operational capacity and internet traffic needs when resources are available [1]. Group 2 - The board believes that this strategic cooperation will promote the development of both companies' businesses by leveraging their respective advantages in digital technology [2]. - The expected outcome of the cooperation includes securing stable supply of operational capacity and internet traffic services under more favorable commercial terms, enhancing the consistency, quality, and competitiveness of the software as a service (SaaS) solutions offered by the group [2]. - This partnership is anticipated to lower overall costs, supporting the long-term development of the new SaaS solutions business [2].

Group 1 - The company announced a placement agreement with a placement agent to issue up to 57.6 million shares at a price of HKD 0.99 per share, subject to approval from the listing committee [1] - The maximum number of placement shares represents approximately 20.00% of the company's existing issued share capital as of the announcement date, and approximately 16.67% of the enlarged issued share capital after the placement [1] - The placement price of HKD 0.99 per share reflects a discount of about 19.51% compared to the closing price of HKD 1.23 on the Hong Kong Stock Exchange on December 29, 2025 [1] Group 2 - If all placement shares are fully placed, the total expected gross proceeds from the placement will be approximately HKD 57.024 million, with a net amount of about HKD 55.784 million after deducting applicable costs and expenses [2] - The net price per placement share is expected to be approximately HKD 0.968 [2] - The net proceeds will be allocated as follows: about 30% for the development of the electronic components trading business, 30% for the development of SaaS solutions and innovative digital products, 30% for the technical upgrade and R&D of the pilot algorithm system (PAS), and the remainder for general working capital [2]

Group 1 - The company, Zhimeng Capital, has entered into a placement agreement to issue up to 57.6 million shares at a price of HKD 0.99 per share, subject to approval from the listing committee [1] - The maximum number of shares to be placed represents approximately 20.00% of the company's existing issued share capital as of the announcement date, and approximately 16.67% of the enlarged issued share capital post-placement [1] - The placement price of HKD 0.99 per share reflects a discount of about 19.51% compared to the closing price of HKD 1.23 on the Hong Kong Stock Exchange on December 29, 2025 [1] Group 2 - If all placement shares are fully placed, the total expected gross proceeds from the placement will be approximately HKD 57.024 million, with a net amount of about HKD 55.784 million after deducting applicable costs and expenses [2] - The net price per placement share is estimated to be around HKD 0.968 [2] - The net proceeds from the placement are intended to be used as follows: approximately 30% for the development of the group's electronic components trading business, 30% for the development of SaaS solutions and innovative digital products, 30% for technology upgrades and R&D of the pilot algorithm system (PAS), and the remainder for general working capital [2]

Core Insights - Deep Longevity, Inc. has appointed Dylan Kay as Chief Business Officer and Luke Shaffer as Vice President of Sales for the United States, effective January 1, 2026, marking its entry into the U.S. health market [1] - The company plans to launch its commercial operations in the first quarter of 2026, focusing on four key areas: corporate health and wellness programs, health insurance and risk-bearing entities, diagnostic laboratories and longevity clinics, and high-end consumer health platforms [1] - Deep Longevity aims to sign over 50 U.S. corporate clients by the end of 2026, positioning its aging clock technology at the center of the preventive healthcare revolution [2] Company Strategy - The appointments of Kay and Shaffer are strategic moves to leverage their extensive experience in health technology and corporate partnerships to drive growth [1][2] - Deep Longevity's clinically validated aging clocks, including BloodAge, EpigeneticAge, MindAge, BiometricAge, and the upcoming FaceAge, provide actionable insights across molecular, physiological, cognitive, and psychological aging dimensions [1] - The company's SaaS solutions enable employers and insurance companies to transition from passive disease care to proactive, quantifiable personalized longevity programs that can extend healthy lifespan and reduce long-term costs [1] Market Context - The U.S. healthcare expenditure is approximately $4.5 trillion annually, with 90% attributed to chronic diseases, highlighting the significant market opportunity for Deep Longevity's solutions [2] - The leadership of Kay and Shaffer is expected to transform emerging science into enterprise-level impact, aligning with the growing focus on preventive healthcare [2]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公佈全部或任何部份內容而 產生或因倚賴該等內容而引致之任何損失承擔任何責任。 （於開曼群島註冊成立之有限公司） （股份代號：���） 自願性更新營運情況 Deep Longevity於美國的業務擴展及 啟動二零二六年前委任主要高管 本公佈乃勵晶太平洋集團有限公司（「本公司」，連同其附屬公司統稱「本集團」）董事 （「董事」）會（「董事會」）按自願基準而作出，以知會本公司股東及潛在投資者下列 有關其營運的最新情況。 本 公 司 今 日 宣 佈，全 球 可 解 釋 人 工 智 能 驅 動 老 化 時 鐘 與 長 壽 科 學 的 領 導 者 Deep Longevity, Inc及其附屬公司（統稱「Deep Longevity」）委任Dylan Kay為 美利堅合眾國（「美國」）首席商務官及Luke Shaffer為美國銷售副總裁，二人均將於 二零二六年一月一日正式履新。 此次委聘標誌著Deep Longevity積極進駐全球最大的健康市場 － 美國，且已定於 二零二六年第一季度啟動商業 ...